Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zimo Yang

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
Orphanet Journal of Rare Diseases|August 13, 2025
ECHS1: pathogenic mechanisms, experimental models, and emerging therapeutic strategiesQiang Fu, Rui Qiu, Shang Li, et al.
Cell Discovery|August 6, 2024
PROTAC for Bruton's tyrosine kinase degradation alleviates inflammation in autoimmune diseasesCan Zhu, Zimo Yang, Yuxiao Zhang, et al.
Journal of Extracellular Vesicles|April 16, 2025
Dendritic Cell Derived-Extracellular Vesicles Engineered to Express Interleukin-12 and Anti-CTLA-4 on Their Surface for Combinational Cancer ImmunotherapyJiangbin Chen, Qi Tan, Zimo Yang, et al.
Journal of Medicinal Chemistry|July 23, 2019
Potent and Preferential Degradation of CDK6 via Proteolysis Targeting Chimera DegradersShang Su, Zimo Yang, Hongying Gao, et al.
Nature Nanotechnology|May 19, 2025
Tumour-derived microparticles obtained through microwave irradiation induce immunogenic cell death in lung adenocarcinomaYali Wu, Wenjuan Chen, Jingjing Deng, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 3, 2025
Cancer-associated fibroblast-derived extracellular vesicles loaded with GLUT1 inhibitor synergize anti-PD-L1 to suppress tumor growth via degrading matrix stiffness and remodeling tumor microenvironmentYali Wu, Wenjuan Chen, Jingjing Deng, et al.
Cancer Letters|July 10, 2024
PI3K PROTAC overcomes the lapatinib resistance in PIK3CA-mutant HER2 positive breast cancerHongyan Zhang, Longlong Zhang, Yuna He, et al.
Cancer Letters|June 30, 2026
Corrigendum to "PI3K PROTAC overcomes the lapatinib resistance in PIK3CA-mutant HER2 positive breast cancer" [Cancer Lett. 598 (2024) 217112]Hongyan Zhang, Longlong Zhang, Yuna He, et al.
The Journal of Physical Chemistry. B|July 1, 2020
Location of the Hydrophobic Surfactant Proteins, SP-B and SP-C, in Fluid-Phase BilayersRyan W Loney, Sergio Panzuela, Jespar Chen, et al.
Acta Pharmaceutica Sinica. B|February 13, 2026
Intratumoral immune-microbial crosstalk shaped by tumor cell-derived extracellular vesicles encapsulating berberine boosts lung cancer immunotherapyJingjing Deng, Wenlong Kuang, Wenjuan Chen, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Orphanet Journal of Rare Diseases|August 13, 2025
ECHS1: pathogenic mechanisms, experimental models, and emerging therapeutic strategiesQiang Fu, Rui Qiu, Shang Li, et al.
Cell Discovery|August 6, 2024
PROTAC for Bruton's tyrosine kinase degradation alleviates inflammation in autoimmune diseasesCan Zhu, Zimo Yang, Yuxiao Zhang, et al.
Journal of Extracellular Vesicles|April 16, 2025
Dendritic Cell Derived-Extracellular Vesicles Engineered to Express Interleukin-12 and Anti-CTLA-4 on Their Surface for Combinational Cancer ImmunotherapyJiangbin Chen, Qi Tan, Zimo Yang, et al.
Journal of Medicinal Chemistry|July 23, 2019
Potent and Preferential Degradation of CDK6 via Proteolysis Targeting Chimera DegradersShang Su, Zimo Yang, Hongying Gao, et al.
Nature Nanotechnology|May 19, 2025
Tumour-derived microparticles obtained through microwave irradiation induce immunogenic cell death in lung adenocarcinomaYali Wu, Wenjuan Chen, Jingjing Deng, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 3, 2025
Cancer-associated fibroblast-derived extracellular vesicles loaded with GLUT1 inhibitor synergize anti-PD-L1 to suppress tumor growth via degrading matrix stiffness and remodeling tumor microenvironmentYali Wu, Wenjuan Chen, Jingjing Deng, et al.
Cancer Letters|July 10, 2024
PI3K PROTAC overcomes the lapatinib resistance in PIK3CA-mutant HER2 positive breast cancerHongyan Zhang, Longlong Zhang, Yuna He, et al.
Cancer Letters|June 30, 2026
Corrigendum to "PI3K PROTAC overcomes the lapatinib resistance in PIK3CA-mutant HER2 positive breast cancer" [Cancer Lett. 598 (2024) 217112]Hongyan Zhang, Longlong Zhang, Yuna He, et al.
The Journal of Physical Chemistry. B|July 1, 2020
Location of the Hydrophobic Surfactant Proteins, SP-B and SP-C, in Fluid-Phase BilayersRyan W Loney, Sergio Panzuela, Jespar Chen, et al.
Acta Pharmaceutica Sinica. B|February 13, 2026
Intratumoral immune-microbial crosstalk shaped by tumor cell-derived extracellular vesicles encapsulating berberine boosts lung cancer immunotherapyJingjing Deng, Wenlong Kuang, Wenjuan Chen, et al.
Pageof 6